SF

Scott Fidel Goldman Sachs Latest Price Targets & Analyst Ratings

Main Sector
Healthcare
Ratings Past Year
27
Avg Return
Past Year
2.7%
Success Rate
Past Year
0 %
Rating Distribution Past Year
Positive 67.9%
Neutral 28.6%
Negative 3.6%
Stock Rating Price Target Upside
Downside
Ratings
1 Year
Avg Return
1 Year
Success Rate
1 Year
Date
Neutral Initiated
$19
30%
upside
4 +2.8%
0 %
14 Oct ‘25 6 days ago
Neutral Assumed
$219
7%
upside
2
14 Oct ‘25 6 days ago
Buy Assumed
$224
12%
upside
1 +5.3%
0 %
14 Oct ‘25 6 days ago
Buy Assumed
$470
10%
upside
1 +3.8%
0 %
14 Oct ‘25 6 days ago
Neutral Initiated
$17
12%
downside
1
14 Oct ‘25 6 days ago
Neutral Initiated
$207
7%
upside
1
14 Oct ‘25 6 days ago
Neutral Initiated
$343
2%
downside
1
14 Oct ‘25 6 days ago
Sell Initiated
$33
6%
downside
2 +3%
0 %
14 Oct ‘25 6 days ago
Buy Initiated
$21
23%
upside
3 +13%
0 %
14 Oct ‘25 6 days ago
Buy Initiated
$91
10%
upside
1 +5.2%
0 %
14 Oct ‘25 6 days ago
Buy Initiated
$370
24%
upside
2 -2.4%
0 %
14 Oct ‘25 6 days ago
Buy Initiated
$406
14%
upside
2 -21%
0 %
14 Oct ‘25 6 days ago
Overweight Reiterated
$142
20%
upside
2 +0.6%
0 %
12 Mar ‘25 7 months ago
Overweight Reiterated
$38
61%
upside
1 +5.1%
0 %
11 Mar ‘25 7 months ago
Equal-Weight Reiterated
$101 1
4 Mar ‘25 7 months ago
Overweight Maintained
$31
153%
upside
1 -30%
0 %
18 Nov ‘24 11 months ago
Overweight Maintained
$167
8%
downside
1 +19%
0 %
28 Oct ‘24 11 months ago
Overweight Initiated
$21
16%
downside
1 +39%
0 %
22 Oct ‘24 1 year ago